NOTICE OF PUBLIC HEARING Notice is hereby given that a public hearing as required by Section 147(f) of the Internal Revenue Code of 1986 (the "Code") will be held telephonically at 9:30 a.m. Eastern Standard Time on March 25, 2026 by the University of Kentucky (the "Issuer"), concerning the proposed issuance, in one or more series or sub-series, as part of a plan of finance, by the Issuer, for the benefit of Royal Blue Health, LLC, who is the sole member-owner of Ashland Hospital Corporation d/b/a King's Daughters Medical Center (the "Borrower"), a nonprofit corporation duly organized and existing under of the laws of the Commonwealth of Kentucky and an organization described in Section 501(c)(3) of the Code, of up to $55,000,000 aggregate principal amount of the Issuer's General Receipts Refunding Bonds (the "Series 2026A Bonds"), pursuant to a resolution or resolutions of the Issuer. The proceeds of the Series 2026A Bonds will be used by the Issuer and the Borrower to finance the costs of (i) refunding in advance of maturity all or a portion of the outstanding City of Ashland, Kentucky Medical Center Revenue Bonds, Series 2016A (Ashland Hospital Corporation D/B/A King's Daughters Medical Center Project) (the "Series 2016A Bonds"); (ii) paying all or a portion of costs of credit enhancement, if any, for the Series 2026A Bonds; and (iii) paying all or a portion of the costs of issuance of the Series 2026A Bonds. The proceeds of the Series 2016A Bonds were used by the Borrower to finance the costs of (a) refunding in advance of maturity all of the then outstanding City of Ashland, Kentucky Medical Center Revenue Bonds (Ashland Hospital Corporation, d/b/a King's Daughters Medical Center Project), Series 2014 (the "Series 2014 Bonds"); (b) to reimburse the Borrower for prior capital expenditures for improvements to the then existing medical center located at 2201 Lexington Avenue, Ashland, Kentucky 41101 (the "Medical Center") owned and operated by the Borrower; (c) funding a debt service reserve for the Series 2016A Bonds; (d) funding capitalized interest for the Series 2016A Bonds; and (e) paying costs of issuance of the Series 2016A Bonds. The proceeds of the Series 2014 Bonds were primarily used to pay the costs of capital expenditures related to the Medical Center. THE BONDS SHALL NOT REPRESENT OR CONSTITUTE A DEBT OR PLEDGE OF THE FAITH AND CREDIT OR THE TAXING POWER OF THE ISSUER, THE COMMONWEALTH OF KENTUCKY, OR ANY POLITICAL SUBDIVISION OF THE COMMONWEALTH OF KENTUCKY. The Issuer reserves the right to issue the Series 2026A Bonds under the above-described plan of financing for less than all of the above-described purposes or in an aggregate amount less than the maximum aggregate amount shown above. Interested persons who wish to express their opinions on the proposed financing may participate in the telephonic public hearing by calling the telephonic conference line at 1-800-611-4071 (a toll-free telephone number), Conference I.D.: 908 206 29#, or by submitting written comments to the address below, provided such written comments are delivered to the Issuer before the time of the public hearing. Additional information concerning the proposed financing may be obtained from, and written comments should be addressed to, the University of Kentucky, 301 Peterson Service Building, Lexington, Kentucky 40506, Attention: Sarah Simpson, Debt and Liquidity Principal Director, Telephone: 859-257-5830, Email: sarah.simpson@uky.edu. This notice is given pursuant to Section 147(f) of the Internal Revenue Code of 1986, as amended. UNIVERSITY OF KENTUCKY IPL0320915 Mar 11 2026